Mandatory drug testing is common in the workplace. A tempting workaround for consumers of therapeutic cannabinoids, such as CBD, is to reach for ‘synthetics’, thinking they do not contain THC, the psychoactive component of cannabis or cannabis-derived products. 

The truth is that synthetic CBD, if its extraction source was the cannabis plant, does contain trace amounts of THC. Removing it completely from the end-product is enormously difficult, and also time-consuming and costly. 

This unintentional residue, even in small amounts, can cause problems in drug testing. The solution is to use CBD that derives from a source that isn’t marijuana. 

We don’t use marijuana at PureForm. That’s why our wellness and pharmaceutical products are free of cannabis-related regulatory scrutiny. We transform aromatic terpene oils from other plant sources into pure – really pure – CBD, entirely free of THC – and also free of any of the plant pesticides, microbial contaminants, or heavy metals that can also come with agricultural cannabis production. 

This process is so good that PureForm has been awarded the Purity Award and the THC Free Award from the prestigious Clean Label Project, an industry watchdog dedicated to transparency and consumer safety. 

DiolPure products whose active ingredient is PureForm CBD can be used with no risk at all of accidental detection of THC or any other unwanted molecule in drug testing. 

DiolPure products contain PureForm CBD™ transformed from aromatic terpenes for pharmaceutical-grade purity. PureForm CBD™ is bioidentical to CBD extracted from hemp and cannabis, but free of any residual cannabinoids like THC or impurities or chemicals that can associate with traditional plant-derived production processes. 

The foregoing is a report on trends and developments in cannabinoid industry research. No product description herein is intended as a recommendation for diagnosis, treatment, cure or prevention of any disease or syndrome.